US2010297140A1PendingUtilityA1
Uses of antibodies
Assignee: A C N 135 493 391 PTY LTD AS TRUSTEE FOR CONCA UNIT TRUSTPriority: Aug 31, 2006Filed: Aug 31, 2007Published: Nov 25, 2010
Est. expiryAug 31, 2026(~0 yrs left)· nominal 20-yr term from priority
Inventors:Antony William Scammell
A61P 35/00A61P 35/04A61P 17/06C07K 16/04C07K 16/02A61K 35/20A61K 35/57C07K 16/2866C07K 16/28G01N 33/57557
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides a method of preparing an antibody-containing milk or egg product for use in preventing and/or treating of a non-infectious medical condition. The invention also provides non-systemic modes of administering pharmaceutical compositions including the antibody-containing milk or egg products, including to the GI tract.
Claims
exact text as granted — not AI-modified1 - 56 . (canceled)
57 . A method of preparing an antibody-containing milk or egg product comprising vaccinating a mammal or a bird and obtaining milk from the mammal or eggs from the bird, wherein the antibody-containing milk or egg product prevents and/or treats a non-infectious medical condition selected from a cancer, a non-cancerous condition and a hyperproliferative condition.
58 . The method of claim 57 , wherein the cancer is selected from a skin cancer, an eye cancer, a bladder cancer, a vaginal cancer, a cervical cancer, an oropharynx cancer, a nasopharynx cancer and a gastrointestinal cancer; wherein the non-cancerous condition is selected from Barrett's oesophagus, colorectal polyps and following colorectal polypectomy; and wherein the hyperproliferative condition is psoriasis.
59 . The method of claim 57 , wherein the mammal or the bird is vaccinated with a molecule from the surface of a mammalian cell, wherein the molecule is selected from EphB1, EphB2, EphB4, EfnA1 and EfnB2.
60 . The method of claim 59 , wherein the molecule is EphB4.
61 . The method of claim 57 , wherein the mammal or the bird is vaccinated with an immunogenic peptide having the sequence, PVAGSCWDAVPAPGPSPSLY, as set forth in SEQ ID NO:4.
62 . A method for preventing and/or treating a non-infectious medical condition selected from a cancer, a non-cancerous condition and a hyperproliferative condition, comprising non-systemically administering to a subject, an antibody-containing milk or egg product prepared by the method of claim 57 .
63 . A method for preventing and/or treating a non-infectious medical condition selected from a cancer, a non-cancerous condition and a hyperproliferative condition, comprising non-systemically administering to a subject, an antibody-containing milk or egg product prepared by the method of claim 59 .
64 . The method of claim 62 , wherein the cancer is selected from a skin cancer, an eye cancer, a bladder cancer, a vaginal cancer, a cervical cancer, an oropharynx cancer, a nasopharynx cancer, and a gastrointestinal cancer; wherein the non-cancerous condition is selected from Barrett's oesophagus, colorectal polyps and following colorectal polypectomy; and wherein the hyperproliferative condition is psoriasis.
65 . The method of claim 62 , wherein the administration comprises introducing the antibody-containing milk or egg product directly into the gastrointestinal tract of the subject.
66 . The method of claim 65 , wherein the antibody-containing milk or egg product is administered orally or rectally.
67 . The method of claim 62 , wherein the antibody-containing milk or egg product is applied topically to the cancer.
68 . A method of treating and/or preventing an oesophageal condition in a patient comprising non-systemically administering to a subject, an anti-EphB4 antibody.
69 . The method of claim 68 , wherein the oesophageal condition is selected from Barrett's oesophagus and oesophageal cancer.
70 . The method of claim 68 , wherein the anti-EphB4 antibody is raised against a peptide having the sequence, PVAGSCVVDAVPAPGPSPSLY, as set forth in SEQ ID NO:4.
71 . An antibody-containing milk or egg product prepared by the method of claim 57 .
72 . An antibody-containing milk or egg product prepared by the method of claim 59 .
73 . A pharmaceutical composition comprising an antibody-containing milk or egg product, wherein the milk or egg product is prepared by the method of claim 57 , and wherein the composition is administered to prevent and/or treat a non-infectious medical condition.
74 . A pharmaceutical composition comprising an antibody-containing milk or egg product, wherein the milk or egg product is prepared by the method of claim 59 , and wherein the composition is administered to prevent and/or treat a non-infectious medical condition.Join the waitlist — get patent alerts
Track US2010297140A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.